Decaudin D - Search Results

1

[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].

Willems L, Suarez F, Messas E, Baubion N, Decaudin D, Fourquet A, Ghez D, Delarue R, Hermine O, Buzyn A, Varet B, Rubio MT. Willems L, et al. Among authors: decaudin d. Bull Cancer. 2010 Feb;97(2):245-54. doi: 10.1684/bdc.2009.0958. Bull Cancer. 2010. PMID: 19819776 Free article. French.

2

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.

Jouffre B, Acramel A, Belnou M, Santolla MF, Talia M, Lappano R, Nemati F, Decaudin D, Khemtemourian L, Liu WQ, Maggiolini M, Eschalier A, Mallet C, Jacquot Y. Jouffre B, et al. Among authors: decaudin d. Sci Rep. 2023 Jan 24;13(1):1326. doi: 10.1038/s41598-023-28062-9. Sci Rep. 2023. PMID: 36693877 Free PMC article.

3

Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16.

Quéméner AM, Bachelot L, Aubry M, Avner S, Leclerc D, Salbert G, Cabillic F, Decaudin D, Mari B, Mouriaux F, Galibert MD, Gilot D. Quéméner AM, et al. Among authors: decaudin d. Life Sci Alliance. 2022 Oct 6;5(12):e202201643. doi: 10.26508/lsa.202201643. Life Sci Alliance. 2022. PMID: 36202613 Free PMC article.

4

Corrigendum to "Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma" [Eur J Cancer 126 (2020) 93-103].

Decaudin D, Dit Leitz EF, Nemati F, Tarin M, Naguez A, Zerara M, Marande B, Vivet-Noguer R, Halilovic E, Fabre C, Jochemsen A, Roman-Roman S, Alsafadi S. Decaudin D, et al. Eur J Cancer. 2023 May;184:199. doi: 10.1016/j.ejca.2023.02.004. Epub 2023 Mar 1. Eur J Cancer. 2023. PMID: 36868971 Free article. No abstract available.

5

Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma.

Glinkina K, Nemati F, Teunisse AFAS, Gelmi MC, Etienne V, Kuipers MJ, Alsafadi S, Jager MJ, Decaudin D, Jochemsen AG. Glinkina K, et al. Among authors: decaudin d. Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):14. doi: 10.1167/iovs.63.13.14. Invest Ophthalmol Vis Sci. 2022. PMID: 36515935 Free PMC article.

6

T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma.

Vincent-Salomon A, Mathiot C, Macintyre E, Girre V, Fourquet A, Mercier C, Fréneaux P, Dumont J, Decaudin D. Vincent-Salomon A, et al. Among authors: decaudin d. Leuk Lymphoma. 2000 Apr;37(3-4):387-91. doi: 10.3109/10428190009089439. Leuk Lymphoma. 2000. PMID: 10752990 No abstract available.

7

High risk of cardiac dysfunction after treatment of secondary acute myeloid leukaemia to breast cancer.

Willems L, Suarez F, Baubion N, Decaudin D, Ghez D, Hermine O, Varet B, Rubio MT. Willems L, et al. Among authors: decaudin d. Ann Oncol. 2009 Mar;20(3):597-9. doi: 10.1093/annonc/mdn776. Epub 2009 Jan 27. Ann Oncol. 2009. PMID: 19174451 Free article. No abstract available.

8

Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.

Validire P, Capovilla M, Asselain B, Kirova Y, Goudefroye R, Plancher C, Fourquet A, Zanni M, Gaulard P, Vincent-Salomon A, Decaudin D. Validire P, et al. Among authors: decaudin d. Am J Hematol. 2009 Mar;84(3):133-9. doi: 10.1002/ajh.21353. Am J Hematol. 2009. PMID: 19199367 Free article.

9

(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

Decaudin D, Mounier N, Tilly H, Ribrag V, Ghesquières H, Bouabdallah K, Morschhauser F, Coiffier B, Le Gouill S, Bologna S, Delarue R, Huynh A, Bosly A, Brière J, Gisselbrecht C. Decaudin D, et al. Clin Lymphoma Myeloma Leuk. 2011 Apr;11(2):212-8. doi: 10.1016/j.clml.2011.03.007. Epub 2011 Apr 9. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21575926 Clinical Trial.

10

Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA. Haberer S, et al. Among authors: decaudin d. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e145-52. doi: 10.1016/j.ijrobp.2011.03.013. Epub 2011 May 24. Int J Radiat Oncol Biol Phys. 2012. PMID: 21605948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page